## Abstract Because there is evidence that central cholinergic mechanisms are depleted in dementia, we studied the effects of central cholinergic augmentation on the memory of 5 patients with Alzheimer disease. Patients received placebo, lecithin, physostigmine, or lecithin plus physostigmine in a
No effect from double-blind trial of physostigmine and lecithin in Alzheimer disease
โ Scribed by Dr Albert Wettstein
- Publisher
- John Wiley and Sons
- Year
- 1983
- Tongue
- English
- Weight
- 342 KB
- Volume
- 13
- Category
- Article
- ISSN
- 0364-5134
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Benzodiazepine agonists have been shown to reduce cognitive functioning by producing attentional deยฎcits similar to those produced by muscarinic antagonists. It has therefore been postulated that benzodiazepine antagonists may improve cognitive function in patients with Alzheimer's disease by indire
## Abstract ## Objective To compare the urateโlowering efficacy and safety of febuxostat, allopurinol, and placebo in a large group of subjects with hyperuricemia and gout, including persons with impaired renal function. ## Methods Subjects (n = 1,072) with hyperuricemia (serum urate level โฅ8.0